Last 12 months
Inside the activity.
0 purchase rows · 27 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 11 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2024 Filed Jun 10, 2024 23:58 UTC |
Sanders Corazon (Corsee) D.Director
|
SaleCommon Stock | 1,737 | $41.10 | $71,390.70 |
DisclosureSEC source: 0000950170-24-071548 · ownership.xml · nonDerivative · entry 1 Sanders Corazon (Corsee) D. · CIK 0001796536 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,248 F1 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| May 02, 2024 Filed May 3, 2024 19:23 UTC |
Crombez EricEVP and Chief Medical Officer
|
SaleCommon Stock | 354 | $43.66 | $15,455.64 |
DisclosureSEC source: 0000950170-24-052788 · ownership.xml · nonDerivative · entry 1 Crombez Eric · CIK 0001653052 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,431 F1 · shares: Represents shares sold to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| April 18, 2024 Filed Apr 19, 2024 20:35 UTC |
Crombez EricEVP and Chief Medical Officer
|
SaleCommon Stock | 142 | $44.10 | $6,262.20 |
DisclosureSEC source: 0000950170-24-046055 · ownership.xml · nonDerivative · entry 1 Crombez Eric · CIK 0001653052 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,785 F1 · shares: Represents shares sold to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| April 16, 2024 Filed Apr 18, 2024 22:06 UTC |
Huizenga Theodore AlanSVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 14 | $42.31 | $592.34 |
DisclosureSEC source: 0000950170-24-045670 · ownership.xml · nonDerivative · entry 1 Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,366 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 17:41 UTC |
Kassberg Thomas RichardCBO & EVP
|
SaleCommon Stock | 11,509 | $49.93 | $574,644.37 |
DisclosureSEC source: 0000950170-24-029780 · ownership.xml · nonDerivative · entry 1 Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 252,823 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.92 to $50.06 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 16:54 UTC |
Fust Matthew KDirector
|
SaleCommon Stock | 7,500 | $50.88 | $381,600.00 |
DisclosureSEC source: 0000950170-24-029040 · ownership.xml · nonDerivative · entry 3 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,860 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.53 to $51.78 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 16:54 UTC |
Fust Matthew KDirector
|
SaleCommon Stock | 2,145 | $50.85 | $109,073.25 |
DisclosureSEC source: 0000950170-24-029040 · ownership.xml · nonDerivative · entry 2 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,360 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $51.78 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 16:54 UTC |
Fust Matthew KDirector
|
SaleCommon Stock | 2,550 | $50.89 | $129,769.50 |
DisclosureSEC source: 0000950170-24-029040 · ownership.xml · nonDerivative · entry 1 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,505 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.53 to $51.78 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:19 UTC |
Kassberg Thomas RichardCBO & EVP
|
GrantStock Option (Right to Buy) · Derivative | 31,400 | $0.00 Strike: $53.69 | $0.00 |
DisclosureSEC source: 0000950170-24-026661 · ownership.xml · derivative · entry 5 Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,400 Underlying: Common Stock · 31,400 shares Expires 2034-03-01 F6 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:19 UTC |
Kassberg Thomas RichardCBO & EVP
|
SaleCommon Stock | 1,011 | $53.76 | $54,351.36 |
DisclosureSEC source: 0000950170-24-026661 · ownership.xml · nonDerivative · entry 4 Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 264,332 F4 · shares: Represents shares sold to pay required tax withholdings due to the vesting of RSUs. F5 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:19 UTC |
Kassberg Thomas RichardCBO & EVP
|
Tax withholdingCommon Stock | 274 | $53.69 | $14,711.06 |
DisclosureSEC source: 0000950170-24-026661 · ownership.xml · nonDerivative · entry 3 Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,343 F3 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:19 UTC |
Kassberg Thomas RichardCBO & EVP
|
GrantCommon Stock | 957 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026661 · ownership.xml · nonDerivative · entry 2 Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,617 F2 · shares: Represents shares of common stock which previously granted performance stock units were converted on March 1, 2024 upon certification of the performance metric. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:19 UTC |
Kassberg Thomas RichardCBO & EVP
|
GrantCommon Stock | 17,800 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026661 · ownership.xml · nonDerivative · entry 1 Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 264,660 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:06 UTC |
KAKKIS EMIL DDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 70,094 | $0.00 Strike: $53.69 | $0.00 |
DisclosureSEC source: 0000950170-24-026625 · ownership.xml · derivative · entry 5 KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,094 Underlying: Common Stock · 70,094 shares Expires 2034-03-01 F6 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:06 UTC |
KAKKIS EMIL DDirector · President & CEO
|
GrantCommon Stock | 3,132 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026625 · ownership.xml · nonDerivative · entry 3 KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 563,913 F3 · shares: Represents shares of common stock which previously granted performance stock units were converted on March 1, 2024 upon certification of the performance metric. F4 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:06 UTC |
KAKKIS EMIL DDirector · President & CEO
|
Tax withholdingCommon Stock | 17,417 | $53.69 | $935,118.73 |
DisclosureSEC source: 0000950170-24-026625 · ownership.xml · nonDerivative · entry 2 KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 560,781 F2 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:06 UTC |
KAKKIS EMIL DDirector · President & CEO
|
GrantCommon Stock | 38,428 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026625 · ownership.xml · nonDerivative · entry 1 KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 578,198 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:23 UTC |
Horn HowardChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 34,200 | $0.00 Strike: $53.69 | $0.00 |
DisclosureSEC source: 0000950170-24-026672 · ownership.xml · derivative · entry 2 Horn Howard · CIK 0001786335 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,200 Underlying: Common Stock · 34,200 shares Expires 2034-03-01 F3 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:23 UTC |
Horn HowardChief Financial Officer
|
GrantCommon Stock | 19,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026672 · ownership.xml · nonDerivative · entry 1 Horn Howard · CIK 0001786335 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,766 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. The amount of securities beneficially owned in column 5 reflects the correction of a typographical error in the Form 4 filed by the Reporting Person on October 10, 2023 (the "October 2023 Form 4"). The accurate number of securities beneficially owned by the Reporting Person in Column 5 of the October 2023 Form 4 is 80,366. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:22 UTC |
Parschauer Karah HerdmanEVP and Chief Legal Officer
|
GrantStock Option (Right to Buy) · Derivative | 31,400 | $0.00 Strike: $53.69 | $0.00 |
DisclosureSEC source: 0000950170-24-026666 · ownership.xml · derivative · entry 4 Parschauer Karah Herdman · CIK 0001677455 · EVP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,400 Underlying: Common Stock · 31,400 shares Expires 2034-03-01 F6 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:22 UTC |
Parschauer Karah HerdmanEVP and Chief Legal Officer
|
SaleCommon Stock | 3,756 | $53.76 | $201,922.56 |
DisclosureSEC source: 0000950170-24-026666 · ownership.xml · nonDerivative · entry 3 Parschauer Karah Herdman · CIK 0001677455 · EVP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,340 F3 · shares: Represents shares sold to pay required tax withholdings due to the vesting of RSUs. F4 · balance_after: Includes 357 shares acquired under the Company's Amended and Restated Employee Stock Purchase Plan on October 31, 2023. F5 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:22 UTC |
Parschauer Karah HerdmanEVP and Chief Legal Officer
|
GrantCommon Stock | 957 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026666 · ownership.xml · nonDerivative · entry 2 Parschauer Karah Herdman · CIK 0001677455 · EVP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,739 F2 · shares: Represents shares of common stock which previously granted performance stock units were converted on March 1, 2024 upon certification of the performance metric. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:22 UTC |
Parschauer Karah HerdmanEVP and Chief Legal Officer
|
GrantCommon Stock | 17,800 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026666 · ownership.xml · nonDerivative · entry 1 Parschauer Karah Herdman · CIK 0001677455 · EVP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,782 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:17 UTC |
Huang Dennis KarlSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 31,400 | $0.00 Strike: $53.69 | $0.00 |
DisclosureSEC source: 0000950170-24-026652 · ownership.xml · derivative · entry 4 Huang Dennis Karl · CIK 0001641217 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,400 Underlying: Common Stock · 31,400 shares Expires 2034-03-01 F5 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:17 UTC |
Huang Dennis KarlSee Remarks
|
Tax withholdingCommon Stock | 470 | $53.69 | $25,234.30 |
DisclosureSEC source: 0000950170-24-026652 · ownership.xml · nonDerivative · entry 3 Huang Dennis Karl · CIK 0001641217 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,002 F3 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F4 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:17 UTC |
Huang Dennis KarlSee Remarks
|
GrantCommon Stock | 957 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026652 · ownership.xml · nonDerivative · entry 2 Huang Dennis Karl · CIK 0001641217 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,472 F2 · shares: Represents shares of common stock which previously granted performance stock units were converted on March 1, 2024 upon certification of the performance metric. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:17 UTC |
Huang Dennis KarlSee Remarks
|
GrantCommon Stock | 17,800 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026652 · ownership.xml · nonDerivative · entry 1 Huang Dennis Karl · CIK 0001641217 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,515 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:15 UTC |
Pinion John RichardSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 31,400 | $0.00 Strike: $53.69 | $0.00 |
DisclosureSEC source: 0000950170-24-026648 · ownership.xml · derivative · entry 5 Pinion John Richard · CIK 0001648096 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,400 Underlying: Common Stock · 31,400 shares Expires 2034-03-01 F6 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:15 UTC |
Pinion John RichardSee Remarks
|
SaleCommon Stock | 4,173 | $53.76 | $224,340.48 |
DisclosureSEC source: 0000950170-24-026648 · ownership.xml · nonDerivative · entry 4 Pinion John Richard · CIK 0001648096 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,268 F4 · shares: Represents shares sold to pay required tax withholdings due to the vesting of RSUs. F5 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:15 UTC |
Pinion John RichardSee Remarks
|
Tax withholdingCommon Stock | 60 | $53.69 | $3,221.40 |
DisclosureSEC source: 0000950170-24-026648 · ownership.xml · nonDerivative · entry 3 Pinion John Richard · CIK 0001648096 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,441 F3 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:15 UTC |
Pinion John RichardSee Remarks
|
GrantCommon Stock | 957 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026648 · ownership.xml · nonDerivative · entry 2 Pinion John Richard · CIK 0001648096 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,501 F2 · shares: Represents shares of common stock which previously granted performance stock units were converted on March 1, 2024 upon certification of the performance metric. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:15 UTC |
Pinion John RichardSee Remarks
|
GrantCommon Stock | 17,800 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026648 · ownership.xml · nonDerivative · entry 1 Pinion John Richard · CIK 0001648096 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,544 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:13 UTC |
Huizenga Theodore AlanSVP, Chief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 2,351 | $0.00 Strike: $67.37 | $0.00 |
DisclosureSEC source: 0000950170-24-026641 · ownership.xml · derivative · entry 5 Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,351 Underlying: Common Stock · 2,351 shares Expires 2027-03-01 F6 · derivative.exercise_date: On March 1, 2022, the Reporting Person was granted an option to purchase 2,351 shares of common stock. The option vests upon the achievement of specified performance criteria. Upon achievement of the performance criteria, 1/3 of the option vests on the date of certification by the Issuer's compensation committee of achievement of the performance criteria, 1/3 of the option vests on March 1, 2024 and 1/3 of the option vests on March 1, 2025. On March 1, 2024, the Issuer's compensation committee certified achievement of the performance criteria for the option, resulting in the vesting of the option of 1,568 shares on that date. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:13 UTC |
Huizenga Theodore AlanSVP, Chief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 8,200 | $0.00 Strike: $53.69 | $0.00 |
DisclosureSEC source: 0000950170-24-026641 · ownership.xml · derivative · entry 4 Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,200 Underlying: Common Stock · 8,200 shares Expires 2034-03-01 F5 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:13 UTC |
Huizenga Theodore AlanSVP, Chief Accounting Officer
|
SaleCommon Stock | 341 | $53.76 | $18,332.16 |
DisclosureSEC source: 0000950170-24-026641 · ownership.xml · nonDerivative · entry 3 Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,380 F3 · shares: Represents shares sold to pay required tax withholdings due to the vesting of RSUs. F4 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:13 UTC |
Huizenga Theodore AlanSVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 121 | $53.69 | $6,496.49 |
DisclosureSEC source: 0000950170-24-026641 · ownership.xml · nonDerivative · entry 2 Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,721 F2 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:13 UTC |
Huizenga Theodore AlanSVP, Chief Accounting Officer
|
GrantCommon Stock | 13,950 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026641 · ownership.xml · nonDerivative · entry 1 Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,842 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:10 UTC |
Crombez EricEVP and Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 2,351 | $0.00 Strike: $67.37 | $0.00 |
DisclosureSEC source: 0000950170-24-026635 · ownership.xml · derivative · entry 4 Crombez Eric · CIK 0001653052 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,351 Underlying: Common Stock · 2,351 shares Expires 2027-03-01 F6 · derivative.exercise_date: On March 1, 2022, the Reporting Person was granted an option to purchase 2,351 shares of common stock. The option vests upon the achievement of specified performance criteria. Upon achievement of the performance criteria, 1/3 of the option vests on the date of certification by the Issuer's compensation committee of achievement of the performance criteria, 1/3 of the option vests on March 1, 2024 and 1/3 of the option vests on March 1, 2025. On March 1, 2024, the Issuer's compensation committee certified achievement of the performance criteria for the option, resulting in the vesting of the option of 1,568 shares on that date. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:10 UTC |
Crombez EricEVP and Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 34,200 | $0.00 Strike: $53.69 | $0.00 |
DisclosureSEC source: 0000950170-24-026635 · ownership.xml · derivative · entry 3 Crombez Eric · CIK 0001653052 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,200 Underlying: Common Stock · 34,200 shares Expires 2034-03-01 F5 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:10 UTC |
Crombez EricEVP and Chief Medical Officer
|
SaleCommon Stock | 1,238 | $53.76 | $66,554.88 |
DisclosureSEC source: 0000950170-24-026635 · ownership.xml · nonDerivative · entry 2 Crombez Eric · CIK 0001653052 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,927 F2 · shares: Represents shares sold to pay required tax withholdings due to the vesting of RSUs. F3 · balance_after: Includes 253 shares acquired under the Company's Amended and Restated Employee Stock Purchase Plan on October 31, 2023. F4 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:10 UTC |
Crombez EricEVP and Chief Medical Officer
|
GrantCommon Stock | 19,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026635 · ownership.xml · nonDerivative · entry 1 Crombez Eric · CIK 0001653052 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,912 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:08 UTC |
Harris ErikEVP & Chief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 34,200 | $0.00 Strike: $53.69 | $0.00 |
DisclosureSEC source: 0000950170-24-026629 · ownership.xml · derivative · entry 4 Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,200 Underlying: Common Stock · 34,200 shares Expires 2034-03-01 F6 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:08 UTC |
Harris ErikEVP & Chief Commercial Officer
|
SaleCommon Stock | 4,768 | $53.76 | $256,327.68 |
DisclosureSEC source: 0000950170-24-026629 · ownership.xml · nonDerivative · entry 3 Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,163 F3 · shares: Represents shares sold to pay required tax withholdings due to the vesting of RSUs. F4 · balance_after: Includes 293 shares acquired under the Company's Amended & Restated Employee Stock Purchase Plan on October 31, 2023. F5 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:08 UTC |
Harris ErikEVP & Chief Commercial Officer
|
GrantCommon Stock | 957 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026629 · ownership.xml · nonDerivative · entry 2 Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,638 F2 · shares: Represents shares of common stock which previously granted performance stock units were converted on March 1, 2024 upon certification of the performance metric. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:08 UTC |
Harris ErikEVP & Chief Commercial Officer
|
GrantCommon Stock | 19,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-026629 · ownership.xml · nonDerivative · entry 1 Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,681 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 20:49 UTC |
KAKKIS EMIL DDirector · President & CEO
|
SaleCommon Stock | 30,000 | $45.00 | $1,350,000.00 |
DisclosureSEC source: 0001209191-24-002989 · doc4.xml · nonDerivative · entry 1 KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 539,770 F1 · shares: The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.69 to $45.87 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| January 02, 2024 Filed Jan 2, 2024 21:06 UTC |
Huizenga Theodore AlanSVP, Chief Accounting Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $21.00 | $0.00 |
DisclosureSEC source: 0001209191-24-000070 · doc4.xml · derivative · entry 3 Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2024-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 1/4th of the option vested one year from January 29, 2014 and then 1/48th of the option vested monthly thereafter. Read SEC document |
| January 02, 2024 Filed Jan 2, 2024 21:06 UTC |
Huizenga Theodore AlanSVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 3,000 | $21.00 | $63,000.00 |
DisclosureSEC source: 0001209191-24-000070 · doc4.xml · nonDerivative · entry 2 Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,892 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Includes 278 shares acquired under the Company's Amended and Restated 2014 Employee Stock Purchase Plan on October 31, 2023. F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 21:07 UTC |
KAKKIS EMIL DDirector · President & CEO
|
SaleCommon Stock | 30,000 | $47.87 | $1,436,100.00 |
DisclosureSEC source: 0001209191-24-000071 · doc4.xml · nonDerivative · entry 1 KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 569,770 F1 · shares: The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.54 to $48.29 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Includes 27 shares acquired under the Company's Amended and Restated 2014 Employee Stock Purchase Plan on October 31, 2023. F4 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| December 20, 2023 Filed Jan 2, 2024 21:06 UTC |
Huizenga Theodore AlanSVP, Chief Accounting Officer
|
GrantCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-000070 · doc4.xml · nonDerivative · entry 1 Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,614 F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.